Literature DB >> 10325341

Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique.

D M Hacek1, D C Dressel, L R Peterson.   

Abstract

Bactericidal testing historically has exhibited variable reproducibility, even when prior standardized methods were employed. Several modifications to the National Committee for Clinical Laboratory Standards (NCCLS) broth macrodilution method are proposed to improve reproducibility. Recommended changes from the approved NCCLS guidelines (M21-A and M26-A) include omitting serum supplementation of Mueller-Hinton broth, incubating tubes at 35 degrees C for 24 h with no agitation until they are sampled, running all tests in duplicate with six dilutions instead of nine, reincubating the test for an additional 24 h to resolve discrepant bactericidal activity test results, using a single 0.1-ml sample from each clear tube for subculture, and adopting an alternate method for calculating endpoint determination. In order to test these recommendations in a clinical laboratory setting, we used the modified methodology on 224 separate tests for bactericidal activity. There were 102 serum bactericidal titer (SBT) and 122 minimum bactericidal concentration (MBC) assays performed. By defining reproducibility as agreement between duplicate tests +/- 1 dilution, we found 207 of 224 tests (92%) were reproducible at the 24-h subculture point (94% for the SBT assay and 91% for the MBC assay). When the 17 assays with discrepant results were incubated an additional 24 h for a second subculture, only 1 of 224 tests (0.4%) remained discrepant. The method used is practical for a clinical laboratory that chooses to perform bactericidal activity testing and assures a high level of reproducibility between duplicate assays. The total cost of a test was approximately $25.00.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325341      PMCID: PMC84976     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.

Authors:  D M Bamberger; L R Peterson; D N Gerding; J A Moody; C E Fasching
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

2.  Evaluation of three newer methods for investigating protein interactions of penicillin G.

Authors:  L R Peterson; D N Gerding; H H Zinneman; B M Moore
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains.

Authors:  K Ishida; P A Guze; G M Kalmanson; K Albrandt; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

4.  MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.

Authors:  C J Shanholtzer; L R Peterson; M L Mohn; J A Moody; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

Review 5.  Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts.

Authors:  L R Peterson; D N Gerding
Journal:  Rev Infect Dis       Date:  1980 May-Jun

6.  Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.

Authors:  J A Moody; C E Fasching; L R Peterson; D N Gerding
Journal:  Diagn Microbiol Infect Dis       Date:  1987-01       Impact factor: 2.803

7.  Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.

Authors:  L R Peterson; D N Gerding; J A Moody; C E Fasching
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

8.  Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.

Authors:  D N Gerding; L R Peterson; J A Moody; C E Fasching
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

9.  Occurrence and reproducibility of the "skip" phenomenon in bactericidal testing of Staphylococcus aureus.

Authors:  M E Gresser-Burns; C J Shanholtzer; L R Peterson; D N Gerding
Journal:  Diagn Microbiol Infect Dis       Date:  1987-04       Impact factor: 2.803

10.  Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.

Authors:  P C Taylor; F D Schoenknecht; J C Sherris; E C Linner
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more
  10 in total

Review 1.  Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.

Authors:  M A Pfaller; D J Sheehan; J H Rex
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007.

Authors:  Maria M Traczewski; Bradley D Katz; Judith N Steenbergen; Steven D Brown
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

3.  The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.

Authors:  Steve P Bernier; Susie Son; Michael G Surette
Journal:  J Bacteriol       Date:  2018-08-24       Impact factor: 3.490

4.  Escherichia coli resistance to nonbiocidal antibiofilm polysaccharides is rare and mediated by multiple mutations leading to surface physicochemical modifications.

Authors:  Laetitia Travier; Olaya Rendueles; Lionel Ferrières; Jean-Marie Herry; Jean-Marc Ghigo
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

5.  Cyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental Factors.

Authors:  Steve P Bernier; Matthew L Workentine; Xiang Li; Nathan A Magarvey; George A O'Toole; Michael G Surette
Journal:  Front Microbiol       Date:  2016-05-18       Impact factor: 5.640

6.  Chemotherapeutic control of Gram-positive infection in white sea bream (Diplodus sargus, Linnaeus 1758) broodstock.

Authors:  Nadia G M Ali; Ibrahim M Aboyadak; Heba S El-Sayed
Journal:  Vet World       Date:  2019-02-23

7.  Antibiotic-Resistant Staphylococcus aureus Does Not Develop Resistance to Vanillic Acid and 2-Hydroxycinnamic Acid after Continuous Exposure in Vitro.

Authors:  Deniz Keman; Ferda Soyer
Journal:  ACS Omega       Date:  2019-09-10

8.  A combination therapy strategy for treating antibiotic resistant biofilm infection using a guanidinium derivative and nanoparticulate Ag(0) derived hybrid gel conjugate.

Authors:  Ananta Dey; Manisha Yadav; Deepak Kumar; Anik Kumar Dey; Sweety Samal; Subhash Tanwar; Debrupa Sarkar; Sumit Kumar Pramanik; Susmita Chaudhuri; Amitava Das
Journal:  Chem Sci       Date:  2022-07-27       Impact factor: 9.969

9.  Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin.

Authors:  Steve P Bernier; David Lebeaux; Alicia S DeFrancesco; Amandine Valomon; Guillaume Soubigou; Jean-Yves Coppée; Jean-Marc Ghigo; Christophe Beloin
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

10.  Species-selective killing of bacteria by antimicrobial peptide-PNAs.

Authors:  Madhav Mondhe; Ashley Chessher; Shan Goh; Liam Good; James E M Stach
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.